AmeriFlex Group’s Checkpoint Therapeutics CKPT Stock Holding History

AmeriFlex Group’s Portfolio CKPT Stock Details CKPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-9,450	Closed	-$38.2K	–	1099
2025 Q1	$38.2K	Sell	9,450 -450	-5%	-$1.5K	0.02%	527
2024 Q4	$28.1K	Buy	+9,900	New	+$33.6K	0.01%	562

AmeriFlex Group's CKPT Position: Q2 2025 in Review

AmeriFlex Group sold out of Checkpoint Therapeutics (CKPT) in Q2 2025, closing a stake of 9,450 shares — an estimated $38.2K sold.

AmeriFlex Group first reported a position in CKPT in Q4 2024 and held it in 2 quarters. The position peaked at $38.2K in Q1 2025. 0 funds tracked by Wall St. Rank hold CKPT as of Q2 2025.

AmeriFlex Group reported no remaining Checkpoint Therapeutics position as of Q2 2025 after selling out during the quarter.
AmeriFlex Group sold 9,450 Checkpoint Therapeutics shares in Q2 2025, an estimated $38.2K.
AmeriFlex Group first reported a position in Checkpoint Therapeutics in Q4 2024 and held it in 2 quarters.
AmeriFlex Group's Checkpoint Therapeutics position peaked at $38.2K in Q1 2025.
0 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2025.

Based on AmeriFlex Group's 13F filing for Q2 2025, filed 21 Jul 2025.